Every claim, its source.

Strong dermatology consensus is to avoid topical retinoids in pregnancy. Oral retinoids are proven teratogens; topical absorption is low (~1–2% for tretinoin) and prospective human studies have not shown a clear rise in malformations, but because the same vitamin-A signalling pathway is involved, the risk-benefit ratio is judged unfavourable and guidelines contraindicate them. This is precaution, not evidence of harm from creams.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Topical retinoid use in women of reproductive age and risk of major congenital malformations: a Nordic cohort study. Br J Dermatol 2026 ↗

Best avoided in pregnancy — not because harm is proven (a small human series showed no increase in adverse events) but because systemic absorption is unusually high for a topical: roughly 35–45% of an applied dose is absorbed, far more than most actives. With well-tolerated brightening alternatives available (azelaic acid, vitamin C, niacinamide + sunscreen), the cautious course is to skip it.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Hydroquinone. StatPearls / NCBI Bookshelf ↗

Depends on dose and area. Low-concentration, rinse-off or leave-on OTC salicylic acid (the ~0.5–2% in most cleansers/toners) is endorsed by ACOG for use in pregnancy — absorption is minimal over small areas. The caution is for HIGH-strength salicylic peels and whole-body or occluded use, where salicylate exposure is higher; those are best deferred. Evidence for real-world topical risk is limited, so this is a concentration nuance, not a blanket ban.

• Topical Acne Treatments. MotherToBaby Fact Sheets (NCBI Bookshelf) ↗
• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

Generally considered fine in pregnancy and a first-line acne option per ACOG. About 5% is absorbed through skin and is then fully metabolised to benzoic acid and excreted, so systemic exposure is very low; no signal for congenital malformation. Start low (2.5%).

• Topical Acne Treatments. MotherToBaby Fact Sheets (NCBI Bookshelf) ↗
• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

One of the preferred actives in pregnancy — it tackles acne, redness and pigment. It occurs naturally in grains, absorption is low (~3–8%), and animal studies showed no harm at high doses. A practical, evidence-supported choice — the reviews just add the sensible caveat to keep it to smaller areas and, for maximum caution, to hold off in the first trimester.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Topical Acne Treatments. MotherToBaby Fact Sheets (NCBI Bookshelf) ↗

Low-strength AHAs are considered well-tolerated topically — reviews put the reassuring range at up to ~10% with pH above 3.5, where systemic absorption is minimal. As with salicylic acid, the only real caution is high-percentage in-office peels. Keep daily SPF, since AHAs raise UV sensitivity.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Chua-Gocheco A, Bozzo P, Einarson A. Safety of skin care products during pregnancy. Can Fam Physician 2011. PMC ↗

Widely regarded as one of the safest pregnancy actives — a form of vitamin B3 that supports the barrier, calms redness and helps pigment. There's no dedicated niacinamide pregnancy study; the closest real evidence is the Cosmetic Ingredient Review Expert Panel's cosmetic-safety assessment — some in-vitro developmental-toxicity testing was mixed, but the Panel's overall conclusion was that niacinamide is well-tolerated as used at cosmetic concentrations, with decades of real-world use and no reported pregnancy-harm signal. That's reassurance from a general ingredient-safety review, not a pregnancy trial.

• Final Report of the Safety Assessment of Niacinamide and Niacin — CIR Expert Panel concluded safe as used in cosmetics. Int J Toxicol 2005. PubMed ↗

Considered well-tolerated in pregnancy — it is an antioxidant the body already makes and uses, with no contraindication reported for topical use. A good brightening alternative to the ingredients you're skipping. Evidence is reassurance-by-absence rather than a trial.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

Considered well-tolerated and can be used freely — it is a large humectant molecule native to skin that mainly holds water at the surface, posing minimal systemic risk.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

A glycosylated form of hydroquinone that slowly releases a small amount of hydroquinone on skin — one review found topical 2% arbutin gives only about 0.27±0.13% dermal absorption, with α-arbutin partially hydrolysing to hydroquinone in the skin. Systemic exposure is far lower than hydroquinone itself, but pregnancy-specific outcome data are essentially absent, so it sits in 'probably low risk — use only if your clinician is comfortable', with azelaic acid or vitamin C as better-characterised swaps.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

A brightening agent with very low systemic absorption. There's no human reproductive-safety data — a mouse study found no maternal or fetal damage, which is reassuring but doesn't establish safety in pregnant humans — and reviews still say it's 'not recommended, and further studies are required.' It's flagged as unstudied in humans, not as harmful; prefer better-characterised options during pregnancy.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗

The concern is theoretical and the evidence limited. Oxybenzone (benzophenone-3) is absorbed (~1–2%, detectable in urine) and has endocrine-disrupting activity in lab and animal studies; a direct effect on human pregnancy is NOT established. Reviews advise using chemical filters with caution and prefer mineral sunscreen (zinc oxide / titanium dioxide) as a simple, well-tolerated swap; guidance is firmest for oxybenzone and octinoxate specifically (some reviews advise avoiding those two outright) and lighter for octocrylene / octisalate. Do not stop using sunscreen — just consider a mineral one.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Photoprotection in pregnancy: addressing safety concerns and optimizing skin health. PMC ↗

The preferred sunscreen filters in pregnancy — these inorganic minerals sit on the skin surface and reflect UV with negligible absorption, and are FDA GRASE. Sun protection matters more than ever because pregnancy raises melasma risk.

• Skin Changes and Safety Profile of Topical Products During Pregnancy (peer-reviewed review). PMC ↗
• Photoprotection in pregnancy — zinc oxide and titanium dioxide are the mineral (inorganic) filters and the only FDA GRASE UV filters. PMC ↗

Essential oils are highly concentrated, and a specific subset has documented reproductive-toxicity signals: pennyroyal (its pulegone is hepatotoxic and a historical cause of poisoning-induced miscarriage), wintergreen (essentially pure methyl salicylate — the same class of concern as oral aspirin), the thujone-rich oils sage, wormwood, mugwort, thuja and tansy (thujone is a convulsant and reproductive toxin), camphor (crosses the placenta to fetal organs), and hyssop/basil (neurotoxic / estragole carcinogenic-potential concerns). Most of this evidence is from animal studies or high-dose or ingested exposure, not low-concentration cosmetic use, so treat it as a reason for caution, not alarm. Rosemary and clary sage are sometimes cautioned against too, but the leading essential-oil-safety literature considers that unsupported at cosmetic-use levels — a lower priority within this caution than the oils above.

• Dosoky NS, Setzer WN. Maternal Reproductive Toxicity of Some Essential Oils and Their Constituents. Int J Mol Sci 2021. PMC ↗

Topical minoxidil (the hair-regrowth active, and a popular postpartum-shedding fix) has no controlled human pregnancy-safety data. A published case report links maternal use to significant fetal brain, heart and vascular malformations, and the OTC drug label itself warns it 'may be harmful if used when pregnant or breast-feeding.' Better to pause it until after pregnancy/breastfeeding, on a clinician's advice.

• Fetal malformation associated with maternal use of topical minoxidil (case report). Birth Defects Res A 2003. PubMed ↗
• Minoxidil topical solution drug label (Warnings) — 'may be harmful if used when pregnant or breast-feeding'. DailyMed, U.S. NLM ↗

No skincare product should contain mercury — and it matters doubly in pregnancy. It's an illegal-but-still-circulating skin-lightening/preservative ingredient, readily absorbed through the skin, and it can damage the kidneys and nervous system. Pregnant women, nursing infants and young children are especially vulnerable, and mercury passes into breast milk. The FDA says stop using any product listing 'mercury', 'mercurous chloride', 'calomel', 'mercuric', or 'mercurio' on the label.

• FDA warns consumers about skin products containing mercury — repeated skin use lets mercury absorb into the bloodstream, causing kidney and neurological damage. U.S. FDA ↗
• Mercury poisoning linked to skin products — label words that mean mercury: 'mercurous chloride', 'calomel', 'mercuric', 'mercurio', 'mercury'; mercury passes into breast milk, so nursing infants are especially vulnerable. U.S. FDA Consumer Update ↗

Malassezia is a lipid-dependent yeast — the founding lab study (Wilde & Stewart, 1968) found it won't grow unless fatty acids longer than about C10 are present, and a 2025 study testing individual fatty acids up to C24 confirmed growth across that window, though very unevenly: palmitic acid (C16) and oleic acid supported the most efficient growth while several others (myristic, arachidic, behenic, lignoceric) only supported weak, limited growth. So 'C11–C24' is a reasonable summary of the tested range, not a claim that every fatty acid in it feeds the yeast equally well — oleic and palmitic are the best-evidenced triggers; several others are flagged mainly for being in the same structural family. Separately, Malassezia's own lipases release oleic acid from sebum, and free oleic acid has been shown to disrupt keratinocyte differentiation and trigger inflammation — a real mechanism, though it describes what the yeast does to sebum rather than a direct test of each cosmetic ingredient on skin.

• Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia Genus in Skin and Systemic Diseases. Clin Microbiol Rev 2012. PMC ↗
• Wilde PF, Stewart PS. Fatty-acid metabolism of Pityrosporum ovale — the yeast grows only if fatty acids of chain length greater than C10 are present. Biochem J 1968. PMC ↗
• Liebregts J, et al. Lipid-dependent growth of Malassezia in defined medium with single fatty acids (C12–C24) — palmitic (C16) and oleic supported the most growth; several others only limited. FEMS Yeast Res 2025. PMC ↗
• Malassezia virulence factors and their role in dermatological disorders (lipase/oleic-acid mechanism). Acta Dermatovenerol APA 2022 ↗

A patch-test caution, not a hard avoid. A 1995 lab study found Malassezia furfur really does hydrolyse synthetic fatty-acid esters back into free fatty acids — ethyl esters (like ethyl oleate) fastest, isopropyl esters (isopropyl palmitate, isopropyl myristate) next — and the released unsaturated fatty acids fed the yeast's growth more than saturated ones did. So the mechanism is real for at least some esters. But this remains the biggest over-flagging bucket: many ubiquitous emulsifiers (glyceryl stearate, PEG-100 stearate) are built so the fatty acid isn't released in a usable form, and many fungal-acne-prone people tolerate them fine, especially in rinse-off. Treat a match as 'worth patch-testing', not 'certainly breaks you out'.

• Mayser P, et al. Hydrolysis of fatty-acid esters by Malassezia furfur — ethyl esters hydrolysed fastest, then isopropyl esters; released unsaturated fatty acids stimulated growth. Acta Derm Venereol 1995. PubMed ↗
• Fungal Acne and Lipids: What Science Actually Says (concentration-dependence & over-flagging critique). Roccoco ↗

The polysorbate emulsifiers are fatty-acid esters of sorbitan (polysorbate 20/40/60/80 ≈ lauric/palmitic/stearic/oleic) and have been shown to support Malassezia growth in vitro, which is why fungal-acne lists flag them. They appear in both rinse-off and leave-on products (as solubilisers), usually far below lab-assay levels, so real-world tolerance varies.

• Fungal Acne (Malassezia) Ingredient Checker (derm-literature-cited trigger list). SkinSort ↗
• Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia Genus in Skin and Systemic Diseases. Clin Microbiol Rev 2012. PMC ↗

Sorbitan fatty-acid esters (the non-ethoxylated cousins of polysorbates — same fatty-acid-plus-sorbitan backbone, without the polyoxyethylene chains) are flagged by analogy, not by direct evidence: polysorbates (Tweens) are a well-documented Malassezia growth substrate used in classic mycology to tell species apart, but no study we could find has tested plain sorbitan esters (Span-type) the same way. Since the fatty-acid ester bond a lipase would need to hydrolyse is chemically the same in both, it's a reasonable inference that sorbitan esters behave similarly — but it is an inference, not a direct finding. Treat this as a soft, analogy-based patch-test flag rather than an evidenced trigger.

• Puig L, et al. Malassezia pachydermatis lipid dependence on synthetic medium — species differentiated by ability to use polyoxyethylene sorbitan esters (Tweens 20/40/60/80). PLoS ONE 2017. PMC ↗

A precautionary, community-driven caution — not a proven trigger. People managing fungal acne often avoid fungal/yeast ferments like Galactomyces on the theory that a yeast-derived ingredient might feed Malassezia, but direct evidence it worsens fungal acne is essentially absent. The mechanism often cited — that Galactomyces activates the aryl-hydrocarbon receptor (AhR) — actually points the other way: Galactomyces-ferment AhR activation is documented as skin-barrier-protective and anti-inflammatory (it restores filaggrin), not a driver of disease. We keep it a soft caution only because it is a live-yeast-derived ferment some people report reacting to. Note: bacterial ferments (Lactobacillus, Bifidobacterium) are NOT in this group and are generally fine.

• Galactomyces fermentation filtrate prevents T helper 2-mediated reduction of filaggrin in an aryl-hydrocarbon-receptor-dependent manner. Clin Exp Dermatol 2015;40(7):786 — GFF's AhR activation is skin-barrier-protective, NOT a driver of Malassezia disease. PubMed 25786502 ↗
• Fungal Acne (Malassezia) Ingredient Checker (derm-literature-cited trigger list). SkinSort ↗

Worth separating from its stable cousin squalane. Squalene is unsaturated and oxidises readily on skin into squalene monohydroperoxide, which is comedogenic — more so than several well-known comedogenic cosmetic ingredients. A 2023 study found Malassezia restricta itself drives this oxidation on skin, producing squalene monohydroperoxide that alters the skin barrier — so the yeast and squalene oxidation are mechanistically linked. Squalane (the saturated, hydrogenated form) has none of this — no double bonds to oxidise — and stays generally fine; squalene is the one to patch-test.

• Comedogenicity of squalene monohydroperoxide in the skin after topical application — oxidised squalene (unlike the saturated, stable squalane) is comedogenic. PubMed 10845185 ↗
• Jourdain R, et al. Malassezia restricta-mediated lipoperoxidation — the yeast drives sebum/squalene peroxidation, producing squalene monohydroperoxide that alters the skin barrier. Acta Derm Venereol 2023 ↗

Chemistry gives a clear reason these shouldn't feed Malassezia: mineral oil and petrolatum are saturated hydrocarbons with no ester bond for a lipase to hydrolyse and no fatty acid to release; silicones (dimethicone, cyclomethicone) aren't lipids in the sense the yeast metabolises; squalane's saturated backbone has no double bonds to oxidise the way squalene does. Malassezia is a lipid-dependent yeast that grows on specific fatty acids, so ingredients carrying no usable fatty acid fall outside what it can metabolise. This is reasoned from that chemistry rather than a dedicated study of each ingredient — a thinner evidence base than the flagged ingredients above, but a well-founded one.

• Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia Genus in Skin and Systemic Diseases. Clin Microbiol Rev 2012. PMC ↗

Caprylic/capric triglyceride (MCT) is built from C8 and C10 fatty acids — both at or below the chain length Malassezia needs to grow at all, per the foundational 1968 study (fatty acids must be longer than C10). Glycerin and propanediol are a different case entirely: they're simple humectant polyols, not fatty acids or fatty-acid esters, so there's no lipid for Malassezia's lipases to act on in the first place. Generally well-tolerated on fungal-acne-prone skin.

• Wilde PF, Stewart PS. Fatty-acid metabolism of Pityrosporum ovale — the yeast grows only if fatty acids of chain length greater than C10 are present. Biochem J 1968. PMC ↗

Keep camphor off babies. It's well absorbed through skin as well as by inhalation and ingestion, and is neurotoxic — fatal doses in children have been as little as 0.7–1 g, camphor/menthol/eucalyptus balms have caused seizures and respiratory distress in infants, and a documented case of skin exposure alone triggered convulsions in a small child. There is no infant skincare need for it.

• Use of Camphor and Essential Oil Balms for Infants in Cambodia — camphor / menthol / eucalyptus balms are toxic to infants (seizures, respiratory distress). J Trop Pediatr / PMC 2017 ↗
• Camphor — UK Poisons Information monograph: well absorbed dermally/by inhalation/ingestion; fatal doses in children 0.7–1.0 g; convulsions after skin exposure in a small child. NPIS/IPCS-INCHEM ↗

Camphor, menthol/eucalyptus (1,8-cineole) and peppermint are the terpenes behind most 'cooling' chest and vapor rubs, and pediatric case reports describe real harm in young children: balms containing them have caused seizures and respiratory distress, and even oral exposure to a small amount of eucalyptus oil in a toddler can cause drowsiness — with more serious reported outcomes (seizures, coma) at higher doses. Pediatric guidance is to keep these off babies, especially chest and face rubs, where a baby is also more likely to inhale or ingest the product.

• Use of Camphor and Essential Oil Balms for Infants in Cambodia — camphor / menthol / eucalyptus balms are toxic to infants (seizures, respiratory distress). J Trop Pediatr / PMC 2017 ↗
• A Pediatric Case of Accidental Eucalyptus Oil Poisoning — eucalyptus / 1,8-cineole causes CNS and respiratory toxicity in young children. PMC 2019 ↗

Oil of wintergreen is almost pure methyl salicylate — extraordinarily concentrated salicylate. In children under 6, a teaspoon (5 mL) or less of oil of wintergreen has been implicated in several documented deaths, and methyl salicylate is also absorbed through skin: a case report in an adult on dialysis showed continued topical absorption kept driving salicylate levels up even during treatment. It has no place in a baby's routine.

• Salicylate Toxicity from Ingestion and Continued Dermal Absorption (methyl salicylate) — case report: an adult on dialysis showed continued topical absorption of methyl salicylate kept driving salicylate levels up even during treatment. PMC ↗
• Davis JE. Methyl salicylate exposure in toddlers — in children <6, a teaspoon (5 mL) or less of oil of wintergreen has been implicated in several documented deaths. J Emerg Med 2007. PubMed ↗

A baby's high skin-surface-to-weight ratio means topical salicylic acid is absorbed far more than in an adult, and genuine salicylate poisoning (salicylism) from topical use has been documented in infants — including a 6-week-old who reached a plasma salicylate level of 580 mg/L after a concentrated salicylic acid preparation was left under occlusion on the scalp for three days. Dermatology guidance says salicylic acid 6% should not be used under age 2, over large areas, for long periods, or under occlusion. Skip it on infants.

• Madan RK, Levitt J. A review of toxicity from topical salicylic acid preparations — dermal absorption is higher in children; salicylic acid 6% should not be used under age 2 or over large areas. J Am Acad Dermatol 2014. PubMed ↗
• Oualha M, et al. Localised topical salicylic acid — an under-recognised infant intoxication risk; 6-week-old reached plasma salicylate 580 mg/L after occluded scalp use. Arch Pédiatr 2012. PubMed ↗

The FDA warns that benzocaine can cause methemoglobinemia — a life-threatening drop in the blood's oxygen-carrying capacity — and should not be used in children under 2; more than 400 cases have been reported since 1971, some fatal. The same caution applies to related numbing agents like lidocaine and prilocaine. Numbing gels, creams and solutions are not something to put on a baby without a doctor directing it.

• Safely Soothing Teething Pain in Infants and Children — benzocaine can cause methemoglobinemia; do not use benzocaine products in children under 2, and viscous lidocaine is not for teething. U.S. FDA ↗

The Cosmetic Ingredient Review concludes borates are safe for adults at ≤5% but explicitly says they 'should not be used on infant or injured skin' — infant and broken skin absorb boron more readily than intact adult skin. A firm avoid for babies, on the CIR's own guidance.

• Amended Safety Assessment of Sodium Borate and Boric Acid as Used in Cosmetics — safe up to ≤5% in adults BUT 'should not be used on infant or injured skin'. Cosmetic Ingredient Review (Expert Panel assessment page) ↗

The EU SCCS found no concentration of methylisothiazolinone safe for leave-on products from a sensitisation standpoint, and pediatric dermatology guidance has specifically flagged reports of allergic contact dermatitis in children linked to MI in wet wipes. It was named the American Contact Dermatitis Society's Allergen of the Year in 2013 amid a documented rise in MI allergy. These preservatives are potent contact allergens — best avoided on infant skin, especially in leave-on products and wipes.

• SCCS Opinion on the safety of Methylisothiazolinone (MI) (P94), sensitisation only (SCCS/1521/13) — for leave-on products (incl. 'wet wipes') no safe MI concentration for induction of contact allergy has been demonstrated. Published version, Regul Toxicol Pharmacol / PubMed 26790577 ↗
• Blume-Peytavi U, et al. Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol 2016. PMC ↗
• Schlichte MJ, Katta R. Methylisothiazolinone: an emergent allergen in common pediatric skin-care products — rising MI allergy; common in wipes; ACDS 2013 Allergen of the Year. Dermatol Res Pract 2014. PMC ↗

Topical retinoids are irritating even on adult skin and their safety and efficacy have not been established in young children — tretinoin's labelling stops at age 12. A baby's barrier can't tolerate them and there is no reason to use one; leave anti-ageing and acne actives out of infant care.

• Tretinoin (topical route) — safety and efficacy have not been established in children under 12 years of age. Mayo Clinic ↗

A skin-lightening drug with no place in baby skincare. Hydroquinone penetrates skin readily — human studies found it well-absorbed through intact adult skin after a single application — and an infant's more permeable, higher-surface-area skin would be expected to absorb at least as much, though this hasn't been separately studied in infants. Pediatric safety and efficacy have not been established, and infants have no need for a depigmenting agent. Avoid.

• Fluocinolone, hydroquinone, and tretinoin (topical) — appropriate studies have not established paediatric safety and efficacy. Mayo Clinic ↗
• Bucks DA, et al. Percutaneous absorption of hydroquinone in humans — penetrates human skin readily after a single topical application (adult forehead-skin data). J Toxicol Environ Health 1988. PubMed ↗

Solvent alcohols are drying and disrupt the barrier, and an infant's immature skin absorbs them more readily than an adult's. The clearest evidence comes from medical, not cosmetic, exposures: full-strength alcohol used to prep a premature infant's skin before catheterization caused necrosis from systemic absorption, and days of ethanol-soaked gauze on a one-month-old's umbilical area caused alcohol intoxication. Those are higher-concentration, prolonged, or occlusive exposures compared with a quick wipe of a dilute cosmetic alcohol — but they show how much more an infant's skin can absorb, which is why drying alcohols like Alcohol Denat. are best avoided in routine baby products. Fatty alcohols like cetyl or cetearyl alcohol are different (gentle emollients) and are not flagged here.

• Harpin V, Rutter N. Percutaneous alcohol absorption and skin necrosis in a preterm infant — alcohol on immature skin is absorbed systemically and can cause necrosis. Arch Dis Child / PMC ↗
• Percutaneous ethyl alcohol intoxication in a one-month-old infant. PubMed ↗

The AAP recommends fragrance-free, hypoallergenic products for babies. Fragrance is a leading cause of contact allergy, and the individually-named ingredients above (limonene, linalool, geraniol…) are the very allergens the EU makes brands declare — a product can even say 'fragrance-free' yet list these. (European pediatric dermatology guidance takes a slightly softer line, allowing fragrance if it's selected from a regulator-approved, lower-allergenicity list — but for babies, going genuinely fragrance-free is the simpler, safer default.)

• Bathing Your Baby — apply a fragrance-free, hypoallergenic moisturiser. HealthyChildren.org (American Academy of Pediatrics) ↗
• Blume-Peytavi U, et al. Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol 2016. PMC ↗

Essential oils are concentrated and under-studied on infants. Tea tree oil has caused documented contact sensitization in children, and lavender and ylang-ylang oils are recognized sensitizers in general dermatology literature (allergenic components like linalool, linalyl acetate and benzyl benzoate are common enough to sit in standard patch-test panels). Some citrus oils are also phototoxic, and infant skin absorbs more of what's applied. This is a caution, not a ban — heavily diluted use of a gentle oil is often tolerated — but for babies, fragrance-free is the safer default and a clinician conversation is sensible.

• Tea tree oil contact sensitisation in children (paediatric contact-allergy report) — tea tree and lavender oils are documented sensitisers, and worse once air-oxidised. Contact Dermatitis / PubMed 32885466 ↗
• Blume-Peytavi U, et al. Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol 2016. PMC ↗
• Sindle A, Martin K. Essential oils — natural products not necessarily safe: lavender (linalool/linalyl acetate) and ylang-ylang (benzyl benzoate, linalool…) are recognised sensitizers in standard patch-test panels. Int J Womens Dermatol 2020. PMC ↗

These preservatives work by slowly releasing formaldehyde, a common contact allergen. Testing of baby wipes has found roughly a quarter of products release detectable formaldehyde — often without it being a declared ingredient — so a wipe or wash can expose a baby to it even when the label doesn't say 'formaldehyde.' Not acutely dangerous the way camphor is, but a sensible thing to avoid on a baby prone to eczema or with already-sensitised skin — prefer a product preserved without them.

• Goossens A, Aerts O. Contact allergy to and allergic contact dermatitis from formaldehyde and formaldehyde releasers: a clinical review and update — a leading paediatric allergen present (sometimes undeclared) in baby wipes/washes; releasers include DMDM hydantoin, quaternium-15, imidazolidinyl/diazolidinyl urea, bronopol. Contact Dermatitis 2022;87(1):20-27. PubMed ↗
• Liou YL, et al. Formaldehyde release from baby wipes — ~24% of tested baby/toddler wipes released formaldehyde, often undeclared. Dermatitis 2019. PubMed ↗

Exfoliating acids thin the stratum corneum and are separately documented to increase sun sensitivity in general cosmetic use — the opposite of what a baby's already more-permeable barrier needs, and infants have no need to exfoliate. Trace lactic acid as a pH buffer in a wash is different; leave-on AHA actives aren't for babies. This is a precautionary call, honestly disclosed: there is no dedicated infant AHA safety study behind it.

• Rahma A, Lane ME. Skin Barrier Function in Infants: Update and Outlook. Pharmaceutics 2022;14(2):433 — the infant barrier can be more permeable (most so in preterm/newborn skin), raising percutaneous absorption. PMC ↗
• Blume-Peytavi U, et al. Recommendations from a European Roundtable Meeting on Best Practice Healthy Infant Skin Care. Pediatr Dermatol 2016. PMC ↗
• Alpha Hydroxy Acids. U.S. FDA Cosmetic Ingredients ↗

The AAP advises avoiding oxybenzone because of concern about mild hormonal properties, and recommends mineral filters (zinc oxide / titanium dioxide) for children. For infants under 6 months, shade and clothing come first — sunscreen only on small areas if unavoidable. Don't stop protecting a baby from the sun; just prefer a mineral formula.

• Sun Safety — 'if possible, avoid the sunscreen ingredient oxybenzone'; choose zinc oxide or titanium dioxide. HealthyChildren.org (American Academy of Pediatrics) ↗
• Baby Sunburn Prevention — keep infants under 6 months out of direct sun; mineral (zinc/titanium) sunscreen only if shade and clothing aren't enough. HealthyChildren.org (AAP) ↗

Propylene glycol is a common, usually well-tolerated humectant, but a neonate's capacity to clear it is reduced — pharmacokinetic studies in preterm/term neonates find the alcohol-dehydrogenase pathway (and renal elimination) immature in the first month of life, so it can accumulate — and transdermal absorption through broken or burned skin caused coma in a premature infant treated with propylene-glycol-based dressings. It is also a weak contact allergen. Low-level use on intact skin is generally fine; the caution is for newborns, high concentrations, and broken skin.

• Peleg O, et al. Coma in a premature infant associated with the transdermal absorption of propylene glycol — neonatal alcohol-dehydrogenase is low, so propylene glycol accumulates. Acta Paediatr 1998. Wiley ↗
• De Cock RFW, et al. Developmental pharmacokinetics of propylene glycol in preterm and term neonates — alcohol-dehydrogenase and renal clearance immature in the first month of life. Br J Clin Pharmacol 2012. PMC ↗
• McGowan MA, Scheman A, Jacob SE. Propylene Glycol in Contact Dermatitis: A Systematic Review — a recognised, if weak, contact allergen and irritant. Dermatitis 2018 ↗

Lanolin is a genuinely useful emollient (it's the basis of many nipple and diaper creams) and outright allergy is uncommon (patch-test positivity ~1.7–3.3% in dermatitis patients, well under 0.5% in the general population), but it was the 2023 Allergen of the Year and sensitisation rises with the repeated, occluded exposure typical of baby creams. Fine for most babies; worth knowing as a possible cause if a rash appears, and worth avoiding on already-broken skin.

• Contact reactions to lanolin (wool alcohols) — a known contact allergen (American Contact Dermatitis Society 2023 Allergen of the Year); prevalence is low (~1.7–3.3% in dermatitis patients, <0.5% general population) but rises with repeated exposure. DermNet ↗

The sunscreen filters the AAP prefers for children — they sit on the surface and reflect UV with minimal absorption, and zinc oxide is also the classic diaper-rash barrier (per AAP's diaper-rash guidance). For babies over 6 months — and small exposed areas under 6 months when shade isn't possible, per AAP's sun-safety guidance — a mineral sunscreen is the recommended choice.

• Sun Safety — 'if possible, avoid the sunscreen ingredient oxybenzone'; choose zinc oxide or titanium dioxide. HealthyChildren.org (American Academy of Pediatrics) ↗
• Common diaper rashes & treatments — 'Zinc oxide and petrolatum are both good choices'. HealthyChildren.org (AAP) ↗

Petrolatum, mineral oil and dimethicone are FDA-recognised skin protectants for general/adult OTC use — inert, non-sensitising occlusives that lock in moisture and support the barrier. They're the workhorses of baby balms and diaper creams, and long clinical practice treats them as well tolerated on infant skin, though dedicated infant-specific safety trials for these individual ingredients are thin — pediatric skin-barrier research flags a broader gap in infant absorption data generally, not a specific concern with these three.

• Skin Protectant Drug Products for OTC Human Use; Final Monograph — petrolatum, white petrolatum, mineral oil, dimethicone and glycerin recognised as safe/effective skin protectants. U.S. FDA (Federal Register) ↗
• Rahma A, Lane ME. Skin Barrier Function in Infants: Update and Outlook. Pharmaceutics 2022;14(2):433 — the infant barrier can be more permeable (most so in preterm/newborn skin), raising percutaneous absorption. PMC ↗

Colloidal oatmeal soothes and supports the barrier, and has been used in infants and young children with eczema with no signal of increased oat sensitisation or food-allergy risk. That said, reviewers still describe the pediatric evidence base as 'under investigation' — promising so far, not yet a large confirmed trial base. A reasonable, low-risk ingredient to see on a baby product.

• Is colloidal oat an effective emollient ingredient for the prevention and treatment of atopic dermatitis in infants? — safely used in infants and young children, with no signal of increased oat sensitisation. J Dermatolog Treat 2025 ↗

Glycerin is a gentle humectant and an FDA-recognised skin protectant (21 CFR 347.10); allantoin is likewise an FDA-recognised OTC skin-protectant active (0.5–2%, same regulation). Panthenol (pro-vitamin B5) has been tested directly in infants — a 4-week study in infants and toddlers 3–36 months found a panthenol-containing emollient well tolerated with good skin acceptability. These are the kind of simple, fragrance-free moisturising ingredients pediatric guidance points parents toward.

• Skin Protectant Drug Products for OTC Human Use; Final Monograph — petrolatum, white petrolatum, mineral oil, dimethicone and glycerin recognised as safe/effective skin protectants. U.S. FDA (Federal Register) ↗
• 21 CFR 347.10 — Allantoin 0.5 to 2 percent, an FDA-recognised OTC skin-protectant active. eCFR/Cornell LII ↗
• A topical panthenol-containing emollient — well tolerated with good skin acceptability in infants/toddlers 3–36 months over 4 weeks. J Dermatolog Treat 2017. PubMed ↗

Never on a baby. Mercury is an illegal-but-still-circulating skin-lightening/antiseptic ingredient; an infant's thin skin absorbs it readily and it damages the developing kidneys and nervous system. Stop using any product that lists 'mercury', 'mercurous chloride', 'calomel', 'mercuric', or 'mercurio'.

• FDA warns consumers about skin products containing mercury — repeated skin use lets mercury absorb into the bloodstream, causing kidney and neurological damage. U.S. FDA ↗
• Mercury poisoning linked to skin products — label words that mean mercury: 'mercurous chloride', 'calomel', 'mercuric', 'mercurio', 'mercury'; mercury passes into breast milk, so nursing infants are especially vulnerable. U.S. FDA Consumer Update ↗

Traditional kohl/kajal/surma on a baby's eyelids is a documented cause of childhood lead poisoning — some products are more than half lead by weight, and lead is a cumulative neurotoxin with no safe level for a child. Use only cosmetics verified lead-free.

• Lead poisoning from traditional eye cosmetics (kohl / kajal / surma) — CDC/MMWR-reported cases; some products are more than half lead by weight. PMC ↗

A once-common antiseptic that is neurotoxic to infants — routine bathing of newborns caused vacuolar brain damage and deaths, which is why the FDA restricted it to prescription use in 1972. It has no place in baby care.

• 21 CFR 250.250 — hexachlorophene restricted to prescription use after neonatal neurotoxicity (vacuolar brain damage / deaths from routine newborn bathing). U.S. FDA (Cornell LII) ↗

Skip peanut oil on a baby's broken or eczematous skin. A case-control study nested in a UK birth cohort found infants whose inflamed skin was treated with peanut-oil creams had higher odds of developing peanut allergy (odds ratio 6.8, but a wide 95% CI of 1.4–32.9 from a single study). Sensitisation appears to happen through damaged skin. Refined peanut oil on intact skin is lower-risk, and the field has since shifted toward encouraging early oral peanut introduction (post-LEAP trial) rather than topical avoidance — but for eczema-prone babies, skipping peanut oil on broken skin remains an easy, low-cost precaution.

• Lack G, et al. Factors associated with the development of peanut allergy in childhood — peanut-oil creams on inflamed infant skin linked to ~6.8× higher odds of peanut allergy. N Engl J Med 2003. PubMed ↗

A skin antiseptic that can cause chemical burns on the fragile skin of premature and very young infants. Following case reports of burns, the FDA required a 'use with care in premature infants or infants under 2 months of age' label change, and the EU's EMA safety committee separately recommended the same caution for newborns — especially those born before 32 weeks or in their first 2 weeks of life. Useful under a clinician, but not for routine at-home use on a newborn.

• Chlorhexidine antisepsis in preterm/neonatal skin: safety review — chemical burns in premature/very-low-birthweight infants; FDA & EMA 'use with care under 2 months' warnings. Pediatr Dermatol 2024. PMC ↗
• EMA PRAC recommendation (Oct 2014) — chlorhexidine may cause chemical skin burns; use with care in newborns, especially <32 weeks and within the first 2 weeks of life. European Medicines Agency ↗

Iodine absorbed through a premature baby's thin skin can overwhelm the immature thyroid. Controlled NICU studies found significantly higher TSH in iodine-exposed preterm infants than those cleaned with chlorhexidine (about 15.4 vs 7.8 mIU/L in one study), and a systematic review put transient hypothyroidism at 12–33% of iodine-exposed infants versus 0% in unexposed ones — the risk concentrated in babies born under 32 weeks. It typically resolves on its own, but guidance is to avoid routine povidone-iodine antiseptic on premature or newborn skin in favour of gentler options. A one-off clinician application, or use on an older, full-term baby, is a lower-risk matter.

• Linder N, et al. Topical iodine-containing antiseptics and subclinical hypothyroidism in preterm infants — TSH 15.4 vs 7.8 mIU/L in iodine- vs chlorhexidine-cleaned preterm infants. J Pediatr 1997. PubMed ↗
• Aitken J, Williams FLR. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine — transient hypothyroidism 12–33% of iodine-exposed vs 0% unexposed. Arch Dis Child Fetal Neonatal Ed 2014. PubMed ↗

Loose talcum powder can be inhaled by a baby and cause serious lung irritation — AAP's own infant-safety guidance says outright not to use baby or talcum powder because inhaled talc can cause severe lung damage and breathing problems, a risk borne out in reported infant aspiration cases. Separately, talc mined near asbestos deposits can carry asbestos contamination — the FDA has found trace asbestos in some tested talc cosmetic products and continues to test for it. Prefer talc-free options; if used at all, keep powder well away from a baby's face.

• Make baby's room safe — 'Do not use baby or talcum powders… inhaled talcum-containing powders can cause severe lung damage and breathing problems in babies'. HealthyChildren.org (AAP) ↗
• Talc — FDA's ongoing asbestos-in-talc testing program (asbestos found in some tested cosmetic talc). U.S. FDA Cosmetic Ingredients ↗